Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Toshiya Morie"'
Autor:
Aya Harada Takeda, Toshiya Morie, Kentaro Jingushi, Masatatsu Yamamoto, Souta Iyama, Ikumi Ohshio, Hiroaki Hase, Shintarou Fujii, Masami Sato, Zenzaburo Tozuka, Yuko Ueda, Kazuhiro Ueda, Kazutake Tsujikawa, Shohei Sato, Kentaro Minami, Takahiro Kogaki, Daisuke Saigusa, Tatsuhiko Furukawa, Toshiyuki Nagata, Masaya Aoki, Kaori Kitae, Kohichi Kawahara, Hasumi Ura
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 197
There are more than 150 types of naturally occurring modified nucleosides, which are believed to be involved in various biological processes. Recently, an ultrahigh performance liquid chromatography-electrospray ionization-tandem mass spectrometry (U
Autor:
Tomoko Kitano, Toshiya Morie, Mitsue Notake, Yayoi Honda, Seiji Iwama, Yuji Sato, Fumiyo Fukuya
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 25:1376-1382
Objectives— We performed a detailed kinetic analysis in a rat balloon injury model to clarify the essential roles of αvβ3 integrin and endothelial cell (EC) regeneration in neointima formation. Using this model, we evaluated the antistenotic effe
Publikováno v:
Tetrahedron. 54:10671-10676
An efficient and practical method for synthesis of the optically active hexahydro-1,4-diazepine 2 , which is a key intermediate of DAT-582, a potent and selective serotonin-3 receptor antagonist, is described. Treatment of the ( R )-1,2,3-trisubstitu
Publikováno v:
Chemical and Pharmaceutical Bulletin. 46:1160-1164
An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine (R-3), which is a key intermediate in the synthesis of DAT-582, a potent and selective serotonin-3 recepto
Publikováno v:
Journal of Synthetic Organic Chemistry, Japan. 56:851-862
Gastrointestinal motility dysfunctions entailed in non ulcer dyspepsia, gastroparesis and reflex oesophagitis are known to be effectively treated with the gastroprokinetic agents e.g. metoclopramide and cisapride. The mechanism of gastroprokinetic ac
Publikováno v:
Tetrahedron: Asymmetry. 8:2367-2374
(±)- N -[1-Methyl-4-(3-methylbenzyl)hexahydro-1 H -1,4-diazepin-6-yl]-1 H -indazole-3-carboxamide (±)- 1 was prepared from N -methyl- N ′-(3-methylbenzyl)-ethylenediamine 5 and 2-(1-benzyloxycarbonyl-1 H -indazole-3-carbonylamino)propenal 4 and w
Publikováno v:
Synthetic Communications. 27:559-566
The convenient large-scale synthesis of the title compound, which is the intermediate of potent 5-HT3 receptor antagonist, N-(1-benzyl-4-memylhexahydro-1H-1,4-diazepin-6-yl)-1H-indazole-3-carboxamide (1), is described.
Publikováno v:
Journal of the Chemical Society, Perkin Transactions 1. :3219-3226
An efficient and practical method for the synthesis of (6R)-6-amino-1-methyl-4-(3-methylbenzyl)hexahydro-1H-1,4-diazepine 2, which serves as the amine part of DAT-582, a potent and selective 5-HT3 receptor antagonist, is described. The key intermedia
Autor:
Toshiya Morie, Shiro Kato
Publikováno v:
Journal of Heterocyclic Chemistry. 33:1171-1178
As a part of metabolic studies of mosapride (1), a potential gastroprokinetic agent, the synthesis of 4-chloro-7-ethoxy-2(3H)-benzoxazolone-6-carboxylic acid (7) as a derivative of 4-amino-5-chloro-2-ethoxy-3-hydroxybenzoic acid (6), which has served
Publikováno v:
Chemical and Pharmaceutical Bulletin. 44:1484-1492
To confirm the proposed structures of the minor metabolites of a potential gastroprokinetic agent, mosapride, 4-amino-5-chloro-2-ethoxy-3-hydroxy-N-(2-morpholinylmethyl)benzamide (3) and the N-(5-oxo-2-morpholinyl)-methyl analogue 4 were prepared. As